LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$374M |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$242M |
| 3 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$242M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$205M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Growth ETF
EFG
|
+$147M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$116M |
| 3 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
+$71M |
| 4 |
Vanguard Russell 1000 Value ETF
VONV
|
+$64.6M |
| 5 |
iShare MSCI Eurozone ETF
EZU
|
+$64.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.89% |
| 2 | Financials | 3.17% |
| 3 | Healthcare | 2.77% |
| 4 | Consumer Discretionary | 2.65% |
| 5 | Industrials | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Oramed Pharmaceuticals
ORMP
$167M
| $99.7K | ﹤0.01% |
43,166
+5,950
| +16% | +$12.7K |
|
|
ADAM
4552
Adamas Trust
ADAM
$815M
| $99.4K | ﹤0.01% |
11,651
-1,525
| -12% | -$12.9K |
|
|
PCM
4553
PCM Fund
PCM
$69.3M
| $99K | ﹤0.01% |
12,440
-6,416
| -34% | -$51K |
|
|
DCH
4554
Dauch Corp
DCH
$1.34B
| $98.4K | ﹤0.01% |
+11,173
| New | +$82.6K |
|
|
CXH
4555
DELISTED
MFS Investment Grade Municipal Trust
CXH
| $98.1K | ﹤0.01% |
12,957
-7,069
| -35% | -$50.2K |
|
4556
Cognyte Software
CGNT
$659M
| $97.3K | ﹤0.01% |
15,137
+4,164
| +38% | +$20.8K |
|
|
UROY
4557
Uranium Royalty Corp
UROY
$1.3B
| $97.2K | ﹤0.01% |
36,001
+16,810
| +88% | +$47.1K |
|
4558
PLAYSTUDIOS Inc
MYPS
$77.9M
| $97.2K | ﹤0.01% |
35,859
-1,027
| -3% | -$2.8K |
|
|
CBIO
4559
Crescent Biopharma
CBIO
$535M
| $96.8K | ﹤0.01% |
410
+280
| +215% | +$43.5K |
|
|
NNDM
4560
Nano Dimension
NNDM
$316M
| $96K | ﹤0.01% |
40,001
+1,000
| +3% | +$2.52K |
|
4561
Oscar Health
OSCR
$9.41B
| $94.9K | ﹤0.01% |
+10,374
| New | +$71.6K |
|
|
STKL
4562
DELISTED
SunOpta
STKL
| $93.4K | ﹤0.01% |
17,070
+150
| +0.9% | +$657 |
|
|
GLO
4563
Clough Global Opportunities Fund
GLO
$250M
| $92.9K | ﹤0.01% |
19,773
-1,300
| -6% | -$5.84K |
|
4564
Toro Corp
TORO
$179M
| $92.5K | ﹤0.01% |
+18,801
| New | +$84.7K |
|
4565
Oric Pharmaceuticals
ORIC
$1.15B
| $92K | ﹤0.01% |
+10,000
| New | +$72.3K |
|
|
ONCT
4566
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $91.9K | ﹤0.01% |
8,573
| – | – |
|
4567
Sana Biotechnology
SANA
$871M
| $91.7K | ﹤0.01% |
22,475
+2,150
| +11% | +$7.92K |
|
|
VRN
4568
DELISTED
Veren
VRN
| $91.5K | ﹤0.01% |
13,200
-1,399
| -10% | -$10.3K |
|
4569
AST SpaceMobile
ASTS
$17.6B
| $91.4K | ﹤0.01% |
15,159
-1,400
| -8% | -$6.07K |
|
4570
Retractable Technologies
RVP
$19.8M
| $89.7K | ﹤0.01% |
80,801
-1,500
| -2% | -$1.68K |
|
|
BGFV
4571
DELISTED
Big 5 Sporting Goods
BGFV
| $89.1K | ﹤0.01% |
14,054
-1,445
| -9% | -$9.28K |
|
|
HTZWW
4572
Hertz Global Holdings Warrants
HTZWW
$66M
| $89K | ﹤0.01% |
16,243
+3,063
| +23% | +$15.5K |
|
4573
Lineage Cell Therapeutics
LCTX
$269M
| $88.3K | ﹤0.01% |
81,014
-14,986
| -16% | -$16.4K |
|
|
SWZ
4574
Swiss Helvetia Fund
SWZ
$76.5M
| $88.2K | ﹤0.01% |
+10,756
| New | +$82K |
|
4575
The Honest Company
HNST
$402M
| $86.1K | ﹤0.01% |
26,091
-232
| -0.9% | -$423 |
|
Similar funds
LPL Financial's Q4 2023 Portfolio in Review
As of Q4 2023, LPL Financial held 4,981 positions worth $165B, up 16% from $143B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
LPL Financial deployed $8.14B of net new capital in Q4 2023, opening 301 new positions and adding to 2,632 existing holdings. Its largest new stake was Veralto: 345,362 shares worth $28.4M.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares MSCI EAFE Growth ETF, an estimated $147M trimmed.
- LPL Financial's largest Q4 2023 buy was Veralto: 345,362 shares worth $28.4M.
- LPL Financial added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $374M increase.
- LPL Financial's biggest Q4 2023 reduction was iShares MSCI EAFE Growth ETF, cutting an estimated $147M.
- LPL Financial fully exited Invesco BulletShares 2023 Corporate Bond ETF in Q4 2023, selling an estimated $71M.
- LPL Financial's ten largest holdings make up 18% of its $165B portfolio in Q4 2023.
- LPL Financial opened 301 new positions and closed 188 in Q4 2023.
- LPL Financial's portfolio value rose 16% quarter-over-quarter to $165B.
Based on LPL Financial's 13F filing for Q4 2023, filed 14 Feb 2024.